Catherine G. Vasilopoulou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Catherine G. Vasilopoulou has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Andreas-David Brunner
Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany
2 shared publications - Florian Meier
Functional Proteomics, Jena University Hospital, Jena, Germany
2 shared publications Karolina Sulek
NNF Center for Protein Research, Copenhagen, Denmark
2 shared publications- Matthias Mann
Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany
2 shared publications Sven W. Meyer
Bruker Daltonics GmbH & Co. KG, Bremen, Germany
2 shared publicationsUlrike Schweiger-Hufnagel
Bruker Daltonics GmbH & Co. KG, Bremen, Germany
2 shared publications
Latest Publications
- Open Access
- 25 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
AP-4-mediated axonal transport controls endocannabinoid production in neurons
The adaptor protein complex AP-4 mediates anterograde axonal transport and is essential for axon health. AP-4-deficient patients suffer from a severe neurodevelopmental and neurodegenerative disorder. Here we identify DAGLB (diacylglycerol lipase-beta), a key enzyme for generation of the endocannabinoid 2-AG (2-arachidonoylglycerol), as a cargo of AP-4 vesicles. During normal development, DAGLB is targeted to the axon, where 2-AG signalling drives axonal growth. We show that DAGLB accumulates at the trans-Golgi network of AP-4-deficient cells, that axonal DAGLB levels are reduced in neurons from a patient with AP-4 deficiency, and that 2-AG levels are reduced in the brains of AP-4 knockout mice. Importantly, we demonstrate that neurite growth defects of AP-4-deficient neurons are rescued by inhibition of MGLL (monoacylglycerol lipase), the enzyme responsible for 2-AG hydrolysis. Our study supports a new model for AP-4 deficiency syndrome in which axon growth defects arise through spatial dysregulation of endocannabinoid signalling.
- 25 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
Open AccessAP-4-mediated axonal transport controls endocannabinoid production in neurons
The adaptor protein complex AP-4 mediates anterograde axonal transport and is essential for axon health. AP-4-deficient patients suffer from a severe neurodevelopmental and neurodegenerative disorder. Here we identify DAGLB (diacylglycerol lipase-beta), a key enzyme for generation of the endocannabinoid 2-AG (2-arachidonoylglycerol), as a cargo of AP-4 vesicles. During normal development, DAGLB is targeted to the axon, where 2-AG signalling drives axonal growth. We show that DAGLB accumulates at the trans-Golgi network of AP-4-deficient cells, that axonal DAGLB levels are reduced in neurons from a patient with AP-4 deficiency, and that 2-AG levels are reduced in the brains of AP-4 knockout mice. Importantly, we demonstrate that neurite growth defects of AP-4-deficient neurons are rescued by inhibition of MGLL (monoacylglycerol lipase), the enzyme responsible for 2-AG hydrolysis. Our study supports a new model for AP-4 deficiency syndrome in which axon growth defects arise through spatial dysregulation of endocannabinoid signalling.
- Open Access
- 6 August 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-4
Reply to “Quality control requirements for the correct annotation of lipidomics data”
- 6 August 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-4
Open AccessReply to “Quality control requirements for the correct annotation of lipidomics data”
- Top Cited PapersOpen Access
- 16 January 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-11
Trapped ion mobility spectrometry and PASEF enable in-depth lipidomics from minimal sample amounts
A comprehensive characterization of the lipidome from limited starting material remains very challenging. Here we report a high-sensitivity lipidomics workflow based on nanoflow liquid chromatography and trapped ion mobility spectrometry (TIMS). Taking advantage of parallel accumulation–serial fragmentation (PASEF), we fragment on average 15 precursors in each of 100 ms TIMS scans, while maintaining the full mobility resolution of co-eluting isomers. The acquisition speed of over 100 Hz allows us to obtain MS/MS spectra of the vast majority of isotope patterns. Analyzing 1 µL of human plasma, PASEF increases the number of identified lipids more than three times over standard TIMS-MS/MS, achieving attomole sensitivity. Building on high intra- and inter-laboratory precision and accuracy of TIMS collisional cross sections (CCS), we compile 1856 lipid CCS values from plasma, liver and cancer cells. Our study establishes PASEF in lipid analysis and paves the way for sensitive, ion mobility-enhanced lipidomics in four dimensions.
- 16 January 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-11
Top Cited PapersOpen AccessTrapped ion mobility spectrometry and PASEF enable in-depth lipidomics from minimal sample amounts
A comprehensive characterization of the lipidome from limited starting material remains very challenging. Here we report a high-sensitivity lipidomics workflow based on nanoflow liquid chromatography and trapped ion mobility spectrometry (TIMS). Taking advantage of parallel accumulation–serial fragmentation (PASEF), we fragment on average 15 precursors in each of 100 ms TIMS scans, while maintaining the full mobility resolution of co-eluting isomers. The acquisition speed of over 100 Hz allows us to obtain MS/MS spectra of the vast majority of isotope patterns. Analyzing 1 µL of human plasma, PASEF increases the number of identified lipids more than three times over standard TIMS-MS/MS, achieving attomole sensitivity. Building on high intra- and inter-laboratory precision and accuracy of TIMS collisional cross sections (CCS), we compile 1856 lipid CCS values from plasma, liver and cancer cells. Our study establishes PASEF in lipid analysis and paves the way for sensitive, ion mobility-enhanced lipidomics in four dimensions.